We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 232

Internet and social media guidance: still wondering whether the FDA will meet its deadline

  • Dechert LLP
  • -
  • USA
  • -
  • June 3 2013

In April, we updated (here) you on the long march to FDA guidance on the promotion of medical products over the Internet and social media. The FDA's

FDA warns companies about links to web sites with health benefit claims

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 31 2013

The U.S Food and Drug Administration (FDA) recently issued a warning letter to dietary supplement manufacturer EuroPharma, Inc., stating that because

Caronia and the First Amendment defense to off-label marketing: a six month re-assessment

  • Morvillo Abramowitz Grand Iason & Anello PC
  • -
  • USA
  • -
  • May 29 2013

When the Second Circuit issued its December 3, 2012 decision in United States v. Caronia, the opinion was proclaimed by many to signal a sea change

FDA delivers its first mobile medical app inquiry

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • USA
  • -
  • May 28 2013

The Food and Drug Administration has taken its first action against a mobile app maker for failure to obtain pre-marketing clearance. Late last week

Time is running out for FDA's online and social media advertising guidance

  • Reed Smith LLP
  • -
  • USA
  • -
  • May 23 2013

Thomas Abrams, director of the Food and Drug Administration (FDA) Office of Prescription Drug Promotion, recently indicated that long-awaited draft

MoFo Tech: SpringSummer 2013

  • Morrison & Foerster LLP
  • -
  • USA
  • -
  • May 22 2013

Behind every trend are new complications. And, often, laws trying to flatten the wrinkles the trends have wrought. Look at social media, for example

Publisher liability rejected by Philadelphia C.P. Court

  • Reed Smith LLP
  • -
  • USA
  • -
  • May 16 2013

Some time ago we were highly critical of a potentially dangerous expansion of liability for failure to warn to publishers of medical literature

NAD recommends goodnighties discontinue claims regarding sleepwear

  • Winston & Strawn LLP
  • -
  • USA
  • -
  • April 29 2013

Following a challenge brought before the National Advertising Division ("NAD"), Goodnighties, Inc. has agreed to discontinue certain claims regarding

FDA knows time is running out on internet and social media guidance

  • Reed Smith LLP
  • -
  • USA
  • -
  • April 29 2013

In a recent interview published by Pharmalot, the Director of the FDA Office of Prescription Drug Promotion (OPDP), Thomas Abrams, indicated that the

FDA says that it knows that the clock is ticking on internet and social media guidance

  • Dechert LLP
  • -
  • USA
  • -
  • April 22 2013

Our readers know that we've been posting about the FDA's obligation to issue guidance on promotion of medical products using the Internet and social